News

Patients prescribed Mounjaro - dubbed the 'King Kong' of injections due to its potency - took to social media concerned they ...
Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...
The quest for weight loss has taken a dramatic turn. A wave of new-age solutions, from once-weekly injectables like Wegovy ...
Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...
Biocon cancels plans to market Novo Nordisk generics in China due to local competition, focusing on other markets.
Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said.
A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...
If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...
Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.
The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...